These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Remission following nitrogen mustard treatment of a case of dermatomyositis]. Kubasiewicz E; Pazdur J; Rytko J; Plachecka-Gutowska M Reumatologia; 1976; 14(1):83-7. PubMed ID: 1257652 [No Abstract] [Full Text] [Related]
23. [Treatment of syringomyelia with I-131]. Skvirskaia KB; Lapchenkov VI Med Radiol (Mosk); 1969 Jan; 14(1):7-9. PubMed ID: 5376472 [No Abstract] [Full Text] [Related]
24. Response of mycosis fungoides to topical chemotherapy with mechlorethamine. Ramsay DL; Parnes RE; Dubin N Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330 [TBL] [Abstract][Full Text] [Related]
25. [Nicotinic acid balance in patients with syringomyelia in the course of deep roentgenotherapy]. Oganesian AA Vrach Delo; 1975 Jul; (7):118-20. PubMed ID: 1220208 [No Abstract] [Full Text] [Related]
30. [Results of the radiotherapy of syringomyelia]. Peresleni NA; Evstigneeva TP; Merkova MA Med Radiol (Mosk); 1967 Jul; 12(7):31-7. PubMed ID: 5603427 [No Abstract] [Full Text] [Related]
31. Induction of tinea cruris by topical nitrogen mustard and by systemic chemotherapy. Shelley WB Acta Derm Venereol; 1981; 61(2):164-5. PubMed ID: 6165198 [TBL] [Abstract][Full Text] [Related]
32. [Craniovertebral decompression and posterior fossa reconstruction treatment of Chiari syringomyelia complex]. Xie J; Ma C; Shan H; Song M; Liu B; Chen X Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):363-5. PubMed ID: 11832059 [TBL] [Abstract][Full Text] [Related]
33. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not? Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030 [TBL] [Abstract][Full Text] [Related]
34. [On the treatment of syringomyelia with radioactive iodine]. Sveshnikova NM; Razumovskaia KI; Obukhov NV Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(6):866-70. PubMed ID: 6000187 [No Abstract] [Full Text] [Related]
35. Value of treating primary causes of syrinx in scoliosis associated with syringomyelia. Ozerdemoglu RA; Transfeldt EE; Denis F Spine (Phila Pa 1976); 2003 Apr; 28(8):806-14. PubMed ID: 12698125 [TBL] [Abstract][Full Text] [Related]
37. [Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood]. Gómez Campderá FJ; López Gómez JM; Cervera A; Gómez Campderá J; Canals MJ; Morales JL; Luque A An Esp Pediatr; 1984 May; 20(8):771-6. PubMed ID: 6476624 [TBL] [Abstract][Full Text] [Related]
38. [Early and late results of treatment of syringomyelia with radioactive iodine]. Mularek J; Gembicki M Neurol Neurochir Pol; 1972; 6(5):861-4. PubMed ID: 4655990 [No Abstract] [Full Text] [Related]
39. Long-term follow-up of Chiari-related syringomyelia in adults: analysis of 157 surgically treated cases. Aghakhani N; Parker F; David P; Morar S; Lacroix C; Benoudiba F; Tadie M Neurosurgery; 2009 Feb; 64(2):308-15; discussion 315. PubMed ID: 19190458 [TBL] [Abstract][Full Text] [Related]
40. [Vasoactive therapy in syringomyelia and degenerative systemic diseases]. Soyka D Munch Med Wochenschr; 1966 Aug; 108(32):1572-5. PubMed ID: 6014386 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]